Hydrogen Peroxide Biocides: EU Authorization 2026 and What Manufacturers and Distributors Must Do

Key data

If your company manufactures, distributes or professionally uses disinfectant products based on hydrogen peroxide, this regulatory change affects you directly. The Commission Implementing Regulation (EU) 2026/2054, published on 14 September 2026, grants a Union authorization for the biocide family "Hydrogen peroxides biocides family", under the Regulation (EU) No 528/2012 on biocides.

The practical result is clear: a single European regulatory framework replaces the patchwork of national authorizations that existed until now. More market access, but also more concrete obligations to comply with.

What does this regulation establish?

Regulation 2026/2054 grants a Union authorization for the family of biocides based on hydrogen peroxide. This means that products included in this family can be marketed and used in all EU Member States under a single authorization title, without the need to obtain individual national permits in each country.

The authorization establishes specific conditions that products must comply with:

• Labeling: products must be labeled in accordance with the specific requirements set out in the authorization.
• Permitted concentrations: only the hydrogen peroxide concentrations expressly authorized are valid.
• Types of authorized use: the authorization defines the uses for which these biocides may be employed.

The reference framework is Regulation (EU) No 528/2012, which regulates the marketing and use of biocides in Europe. The novelty of 2026/2054 is that, for the first time, this family of products has a Union-level authorization, which harmonizes access to the single European market for these disinfectants.

Economic and operational impact

The single EU authorization has two sides for companies in the sector:

Opportunities:

• Elimination of costs and time associated with processing national authorizations in each Member State where you want to market.
• Simplified access to the single European market for manufacturers and distributors, with a single authorization file valid throughout the EU.
• Greater legal certainty for investments in production and distribution on a European scale.

Obligations and operational costs:

• Review and adaptation of labeling of all products in the family to comply with the specific requirements of the authorization.
• Verification that the hydrogen peroxide concentrations used in each product are within the authorized ranges.
• Verification that the declared uses of each product match the types of use authorized by the regulation.
• Update of technical sheets, product documentation and marketing materials to reflect the new regulatory basis.

For companies that already operated with national authorizations in several countries, the net impact is positive: the administrative burden is reduced in the long term. For those who had not yet obtained authorizations in all European markets of interest, this regulation opens the door immediately.

Who does it affect?

• Manufacturers of biocide products based on hydrogen peroxide that market in the EU.
• Distributors of these products in the European market.
• Professional users of hydrogen peroxide biocides, especially in the following sectors:
  • Healthcare and hospital sector (disinfection of surfaces and instruments).
  • Food industry (disinfection of facilities, equipment and food contact surfaces).
  • Industry in general (industrial disinfection of processes and spaces).
• Procurement and regulatory compliance managers in companies that use these products regularly.
• Regulatory advisors and consultants who manage the registration and authorization of biocide products for their clients.

Practical example

Imagine a Spanish company manufacturing disinfectants for the food industry that until now marketed its hydrogen peroxide-based products in Spain, France and Germany. To operate in each country, it had to process and maintain three separate national authorizations, with their respective administrative costs, timelines and differentiated labeling requirements.

With the entry into force of Regulation 2026/2054, this company can benefit from the Union authorization for the "Hydrogen peroxides biocides family". This allows it to operate with a single authorization file valid throughout the EU, simplifying its regulatory management and reducing the cost of maintaining multiple authorizations.

In return, it will need to review the labeling of its products to ensure compliance with the specific requirements set out in the authorization, verify that the hydrogen peroxide concentrations used are within the permitted ranges, and confirm that the declared uses match the types of use authorized by the regulation. If it wants to expand to new European markets, it no longer needs to initiate a new national procedure: the Union authorization covers it directly.

What should companies do now?

1. Identify if your products are included in the authorized family: verify if the biocides you manufacture, distribute or professionally use belong to the "Hydrogen peroxides biocides family" covered by Regulation 2026/2054.
2. Review the labeling of all affected products: check that it complies with the specific requirements established in the authorization and update where necessary.
3. Verify concentrations and types of use: ensure that the hydrogen peroxide concentrations and declared uses of each product are within the parameters authorized by the regulation.
4. Update technical and commercial documentation: safety data sheets, product specifications and sales materials must reflect the new regulatory basis.
5. Evaluate whether to adopt the Union authorization: if you operated with national authorizations in several countries, analyze with your regulatory advisor whether the transition to the single EU authorization is advantageous for your company.
6. Consult the full text of the authorization: the specific conditions (labeling, concentrations, types of use) are detailed in the Commission Implementing Regulation (EU) 2026/2054 published in the EU Official Journal.

Official source

Consult complete regulation in official source

Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602054